Featured Pharma Online Editorial

1. Bridging The Atlantic: A European Executive's Guide To Entering The U.S. RNA Market (Pt. 1) 7/13/2026

   A practical roadmap for European biotech leaders navigating FDA expectations, market entry, and the strategic decisions that shape U.S. expansion.

2. Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains 6/19/2026

   Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.

3. Lilly's Toolbox For Fast Track Fill Finish Sites 4/1/2026

   Constructing greenfield fill finish sites is always a complex task, but throw in there the added challenge of delivering the site expediently, and the task becomes increasingly complicated.

4. 4 Facility Considerations for API Manufacturing 3/25/2026

   Success depends not only on equipment and infrastructure, but also on specialized workforce training, rigorous quality control, robust data management, and increasingly sophisticated supply chain and manufacturing technologies.

5. Ever Wonder What Running A $50B Capital Facilities Project Feels Like? 3/23/2026

   Eli Lilly and Company's projects in the U.S. include greenfield sites where little infrastructure exists. Here's how the company's approaching the challenge.

6. U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/18/2026

   Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

7. At Base Camp: Lilly's Manufacturing Capacity Journey 2/13/2026

   In 2025 alone, Lilly announced plans to build new facilities in Texas, Alabama, Virginia and Pennsylvania in addition to facility expansions in Indiana, Wisconsin and Puerto Rico.

8. The U.S. Has A New Vice To Squeeze Foreign Imports: Pharma Quality 2/13/2026

   The Trump administration has effectively merged national security, trade policy, and drug quality. Now, foreign manufacturers lacking deals face paying a "quality tax."

9. Novo's Path To The First GLP-1 Weight Loss Pill 1/23/2026

   The race to the finish line for the first oral GLP-1 treatment for weight loss was won on Dec. 22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

10. A Deeper Look At Pharma's Structural Supply Chain Vulnerability 12/31/2025

    Fixing limited capacity in pharmaceutical CMC development starts with understanding a complex web of root causes.